Single-Cell Printer for NCATS Stem Cell Translation Laborator - CloneSelect brand-name or equal

STREAMLINED SOLICITATIONFOR COMMERCIAL ITEMS

COMBINED SYNOPSIS / SOLICITATION
COMPETITIVE

Title: Single-Cell Printer for NCATS Stem Cell Translation Laboratory - CloneSelect brand-name or equal.

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

(ii) The solicitation number is 75N95019Q00023 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures and FAR Part 12-Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2019-01 dated 1/22/2019.

(iv) The associated NAICS code 334516 and the small business size standard is 1000 employees. This requirement is full and open with no set-aside restrictions.

(v) The device is a single-cell printer that is brand-name or equal to the CloneSelect Single-Cell Printer model CLONESELECT-SCP, manufactured by Molecular Devices, Inc.

(vi) A brand-equal device will be a single-cell printer that enables gentle, fully automated single-cell plating into microwell plates for iPSCs clonal expansion. The device must be able to single-cell sort cells into microwell plates with an efficiency greater than 80%, provide increased cell viability of 75%, feature use of disposable single-use cell printing microfluidic cartridges to reduce contamination and generate pico-liter droplets that encapsulate cells, and posess FDA approval for monoclonality, image-based documentation and 5-40um cell range coverage.

(vii) Delivery must occur within 2 to 6 weeks after receipt of the order, FOB origin, to:

The National Center for Advancing Translational Sciences
9800 Medical Center Drive
Rockville, MD 20850-6518

(viii) The provision at FAR clause 52.212-1, Instructions to Offerors - Commercial Items, applies to this acquisition.

(ix) The provision at FAR clause 52.212-2, Evaluation - Commercial Items, applies to this acquisition.

(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers:

(1) Technical factors:
• Ability to perform gentle, fully automated single-cell plating into microwell plates for iPSCs clonal expansion;
• Ability to sort single cells into microwell plates with an efficiency greater than 80%;
• Ability to provide average cell viability of 75%;
• Printing speed;
• Ability to use disposable single-use cell printing microfluidic cartridges to reduce contamination;
• Ability to generate pico-liter droplets that encapsulate cells;
• Posess FDA approval for monoclonality, image-based documentation and 5-40um cell range coverage;
• Ability to deliver within 2 to 6 weeks after receipt of order.
(2) Past performance
(3) Price

Technical and past performance, when combined, are significantly more important than cost or price.

(b) Options. The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s).

(c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer's specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.

(x) Offers must include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer.

(xi) The FAR clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. The following addendum applies:

CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses:

For FAR clauses: https://www.acquisition.gov/browsefar

For HHSAR clauses: https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html\

(end of clause)

The following FAR clauses are incorporated by reference:

52.204-7, System for Award Management (Oct 2018)
52.204-13, System for Award Management Maintenance (Oct 2018)
52.204-16, Commercial and Entity Code Reporting (Jul 2016)
52.204-18, Commercial and Entity Code Maintenance (Jul 2016)

52.212-4(g), Invoice, is supplemented by the NIH Invoice and Payment Instructions (2/2014).

(xii) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition, and is attached.

(xiv) Responses to this solicitation must include sufficient information to establish the interested parties' bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s); product description; and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations.

Respondents proposing on an equal product of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order.
In addition, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

All responses must be received by 1:00 pm Eastern time, Thursday, February 7, 2019, and reference solicitation number 75N95019Q00023. Responses must be submitted electronically to Stuart Kern, Contract Specialist, stuart.kern@nih.gov, telephone 301-402-3334.

Fax responses will not be accepted.

.